West Pharmaceutical Services Total Long Term Liabilities 2010-2024 | WST

West Pharmaceutical Services total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • West Pharmaceutical Services total long term liabilities for the quarter ending September 30, 2024 were $0.407B, a 15.16% increase year-over-year.
  • West Pharmaceutical Services total long term liabilities for 2023 were $0.277B, a 32.99% decline from 2022.
  • West Pharmaceutical Services total long term liabilities for 2022 were $0.413B, a 7.44% increase from 2021.
  • West Pharmaceutical Services total long term liabilities for 2021 were $0.384B, a 11.84% decline from 2020.
West Pharmaceutical Services Annual Total Long Term Liabilities
(Millions of US $)
2023 $277
2022 $413
2021 $384
2020 $436
2019 $427
2018 $299
2017 $303
2016 $358
2015 $357
2014 $460
2013 $528
2012 $573
2011 $501
2010 $499
2009 $521
West Pharmaceutical Services Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $407
2024-06-30 $279
2024-03-31 $273
2023-12-31 $277
2023-09-30 $353
2023-06-30 $411
2023-03-31 $413
2022-12-31 $413
2022-09-30 $389
2022-06-30 $372
2022-03-31 $384
2021-12-31 $384
2021-09-30 $382
2021-06-30 $428
2021-03-31 $428
2020-12-31 $436
2020-09-30 $416
2020-06-30 $411
2020-03-31 $412
2019-12-31 $427
2019-09-30 $351
2019-06-30 $365
2019-03-31 $366
2018-12-31 $299
2018-09-30 $306
2018-06-30 $304
2018-03-31 $301
2017-12-31 $303
2017-09-30 $314
2017-06-30 $312
2017-03-31 $308
2016-12-31 $358
2016-09-30 $356
2016-06-30 $356
2016-03-31 $353
2015-12-31 $357
2015-09-30 $371
2015-06-30 $361
2015-03-31 $358
2014-12-31 $460
2014-09-30 $461
2014-06-30 $511
2014-03-31 $546
2013-12-31 $528
2013-09-30 $581
2013-06-30 $610
2013-03-31 $623
2012-12-31 $573
2012-09-30 $535
2012-06-30 $463
2012-03-31 $460
2011-12-31 $501
2011-09-30 $478
2011-06-30 $527
2011-03-31 $520
2010-12-31 $499
2010-09-30 $509
2010-06-30 $493
2010-03-31 $490
2009-12-31 $521
2009-09-30 $535
2009-06-30 $523
2009-03-31 $514
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.239B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49